Related Experiment Video
Updated: Feb 1, 2026

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
Published on: May 11, 2020
Vaccination against HPV virus: a systematic review of economic evaluation studies for developed countries
Dimitris Kostaras1,2, Eleftheria Karampli1, Kostas Athanasakis1
1a Department of Health Economics , National School of Public Health , Athens , Greece.
Introduction:
During the last years, a significant number economic evaluations of HPV vaccination has been published. Given that cost-effectiveness constitutes an essential part of decision-making with regards to the reimbursement of a health technology, the purpose of this study is to provide a supportive tool to decision-makers regarding the economic efficiency of the introduction of HPV vaccination to national immunization programs.
Areas Covered:
The PubMed database was searched in order to identify cost-effectiveness studies for HPV vaccination. A total of 42 articles were finally retrieved. All retrieved cost-effectiveness ratios (ICERs) were converted in the same currency unit (I$) and then inflated to the same year (2015) in order to facilitate cross-country comparisons.
Results:
Overall, vaccination against HPV 6,11,16,18 types appears to have a ICER with mean value of I$25132/QALY, whereas the mean ICER of vaccination against oncogenic HPV 16,18 types is estimated at I$38,253/QALY.
Expert Commentary:
HPV vaccination would be a cost-effective intervention in the setting of high-income countries and could reduce the incidence of HPV-related diseases.
Related Concept Videos
Vaccinations
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Sustainable Development
What are Viruses?
Random and Systematic Errors

